Physical Activity Drop-out Ratio in Patients Living With Type 2 Diabetes
A Socio-ecological Approach to Reduce the Physical Activity Drop-out Ratio in Primary Care-based Patients With Type 2 Diabetes: The SENWI Study Protocol for a Randomized Control Trial.
1 other identifier
interventional
96
1 country
5
Brief Summary
Physical activity (PA) - understood as any bodily movement produced by skeletal muscular that requires energy expenditure, related to leisure time, for transport to get to and from places, or part of a person's work - is a powerful force for good regarding type 2 diabetes mellitus (T2DM). However, fewer T2DM patients sustain the lifestyle recommendations suggested by health care professionals (HCP): 40% of patients did not follow-up on general medical recommendations regarding lifestyle changes. Using a socio-ecological approach - that aims to deal with the different levels of PA influences - may be a good solution to integrate the behaviour change techniques in health care professionals' consultations to prescribe PA efficiently. The investigators' protocol has two aims. The primary aim is to evaluate the effectiveness of theory-driven PA intervention based on SEM among people living with T2DM. A secondary aim is to explore the feasibility and perceptions/experiences on the PA adherence process in T2DM patients while using the socio-ecological approach and to understand the HCP's viewpoint in its applicability in the Spanish Healthcare system. The investigators want to know the how, not the what, related to PA prescription.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes-mellitus-type-2
Started May 2022
Typical duration for not_applicable diabetes-mellitus-type-2
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2021
CompletedFirst Posted
Study publicly available on registry
December 15, 2021
CompletedStudy Start
First participant enrolled
May 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2024
CompletedJune 16, 2022
June 1, 2022
6 months
November 2, 2021
June 13, 2022
Conditions
Outcome Measures
Primary Outcomes (5)
Participant physical activity drop-out ratio
During the intervention, drop out will be considered as less than 80% of assistance at schedule sessions. After the intervention, PA drop out will be measured asking the participants if they continue to undertake PA in their daily life. Participants will be asked once a month until the 24-month (21-month post-intervention) throughout telephone calls and messages (using ecological memorial assessments) about the following-up. What will be important if they do any kind of PA, no matter what kind. The answer will be registered as yes or no.
up to 12 weeks
Participant physical activity levels
PA levels will be assessed throughout activPAL3™ micro
up to 12 weeks
Participant physical activity levels
PA levels will be assessed throughout activPAL3™ micro
2 years
Metabolic participants outcomes
HbA1c analysis from blood sample
up to 12 weeks
Metabolic participants outcomes
HbA1c analysis from blood sample
2 years
Secondary Outcomes (1)
Socioeconomic participant status
Before the intervention
Other Outcomes (2)
Medication patients intake
up to 12 weeks
Medication patients intake
2 years
Study Arms (3)
Nordic Walking Group
ACTIVE COMPARATOREach group will be received 26 sessions of nordic walking. In each session, the intensity will be controlled and expected to be between 3 to 5 in the Borg scale adaptation. Patients will receive a schedule with all three-month sessions.
Physical activity base on SEM (Socioecological models)
EXPERIMENTALThe intervention group based on SEM will apply nordic walking in the same way as the Nordic Walking group. However, in this group, instructors will apply a SEM (instructors will not be the same as in the Nordic Walking group): in each session, the instructors in charge of the Nordic Walking will be also in charge to prescribe the PA.
Congrol group
NO INTERVENTIONControl group outcomes assessment will be the same as the intervention group. However, they will receive common health care professional advice. A common health care professional advice used to recommend patients to walk more and do more PA or physical exercise at the gym. Visits with doctors and nurses will be the same as the intervention group. The difference will be that at intervention group nurses will refer participants to the instructor's physiotherapist to promote PA throughout nordic walking and use the SEM to apply it.
Interventions
To implement this model this intervention aims to address three key elements: 1) prepare the user; 2) structure the action; and 3) design the context. These goals will be worked in each session of Nordic Walking during the warm-up and cool-down and, if necessary, during the session (as long as it's non-stop or slowing down).
Sessions will be progressive: the first month will long 30 minutes, the second month 35 minutes, and the third month 40 minutes (without 10 minutes warm-up and 10 minutes cool-down each session). The track will not have more than 100 accumulate high and will allow doing 5 kilometers without stopping. The meeting point will be between the Biomedical Research Park (Barcelona) and Hospital del Mar (nearby CAP Sant Joan). All sessions will be conducted by an instructor of nordic walking physiotherapists.
Eligibility Criteria
You may qualify if:
- Patients with T2D
- Be eligible to be referred by their doctors for PA intervention;
- Have no major physical limitations prescribed by the doctor or any HCP
- Physical inactive according to the General Practice Physical Activity Questionnaire - GPPAQ screening tool.
You may not qualify if:
- Pregnant patients or have T2D due to gestation
- Inability to freely consent to take part in the study
- Inability to understand the study materials or PA intervention
- T2D patients with complications as neuropathy, retinopathy, and nephropathy
- Contraindications to do PA
- Body Mass Index over 34,9
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Hospital Sant Bernabé
Berga, Barcelona, 08600, Spain
Centre d'Atenció Primaria Anoia
Igualada, Barcelona, 08700, Spain
Centre d'Atenció Primaria les Bases
Manresa, Barcelona, 08241, Spain
Monistrol de Montserrat CAP
Monistrol de Montserrat, Barcelona, 08691, Spain
Centre d'Atenció Primaria Vic Sud
Vic, Barcelona, 08500, Spain
Related Publications (2)
Jabardo-Camprubi G, Donat-Roca R, Sitja-Rabert M, Mila-Villarroel R, Bort-Roig J. Drop-out ratio between moderate to high-intensity physical exercise treatment by patients with, or at risk of, type 2 diabetes mellitus: A systematic review and meta-analysis. Physiol Behav. 2020 Mar 1;215:112786. doi: 10.1016/j.physbeh.2019.112786. Epub 2019 Dec 18.
PMID: 31863856BACKGROUNDJabardo-Camprubi G, Bort-Roig J, Donat-Roca R, Mila-Villarroel R, Sitja-Rabert M, McKenna J, Puig-Ribera A. A socio-ecological approach to reduce the physical activity drop-out ratio in primary care-based patients with type 2 diabetes: the SENWI study protocol for a randomized control trial. Trials. 2022 Oct 3;23(1):842. doi: 10.1186/s13063-022-06742-7.
PMID: 36192800DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guillem Jabardo-Camprubí
University of Vic - Central University of Catalonia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The trial has an open design with a blind assessment of outcomes. Researchers conduction the baseline assessments will be blind to group allocation. The statistician (RMV) will also be blind to group allocation until the completion of the statistical analysis. Participants will be asked not to reveal group allocation when undergoing follow-up measurements. To assess the extent to which blinding has been preserved, researchers will record the number of cases in which allocation was revealed.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 2, 2021
First Posted
December 15, 2021
Study Start
May 1, 2022
Primary Completion
October 30, 2022
Study Completion
April 30, 2024
Last Updated
June 16, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share
Publishing an article in an open journal